MARKET

PMCB

PMCB

Pharmacyte Biotech Inc
NASDAQ
1.220
+0.010
+0.83%
After Hours: 1.150 -0.07 -5.74% 19:59 12/05 EST
OPEN
1.285
PREV CLOSE
1.210
HIGH
1.510
LOW
1.110
VOLUME
22.09M
TURNOVER
--
52 WEEK HIGH
1.900
52 WEEK LOW
0.6300
MARKET CAP
8.29M
P/E (TTM)
-2.5804
1D
5D
1M
3M
1Y
5Y
1D
PharmaCyte Biotech Faces Nasdaq Non-Compliance Notice
TipRanks · 1d ago
PharmaCyte Biotech Receives Noncompliance Notice From Nasdaq; Has Until June 2026 To Regain Compliance
Benzinga · 1d ago
PHARMACYTE BIOTECH INC - RECEIVES NOTICE OF NON-COMPLIANCE WITH NASDAQ RULE - SEC FILING
Reuters · 1d ago
PHARMACYTE BIOTECH : WILL CONSIDER ALL AVAILABLE OPTIONS TO REGAIN COMPLIANCE, INCLUDING, IF APPROPRIATE, IMPLEMENTING REVERSE STOCK SPLIT
Reuters · 1d ago
PharmaCyte Biotech Faces Nasdaq Delisting Risk Over Bid Price Rule Compliance
Reuters · 1d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 2d ago
Weekly Report: what happened at PMCB last week (1124-1128)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 11/26 12:05
More
About PMCB
PharmaCyte Biotech, Inc. is a biotechnology company, which is focused on developing cellular therapies for cancer based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC) will be developed. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used as a means to produce various biologically active molecules. The technology is intended to result in the formation of pinhead-sized cellulose-based porous capsules in which genetically modified live human cells can be encapsulated and maintained. In a laboratory setting, this proprietary live cell encapsulation technology has been shown to create a micro-environment in which encapsulated cells survive and flourish.

Webull offers Pharmacyte Biotech Inc stock information, including NASDAQ: PMCB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PMCB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PMCB stock methods without spending real money on the virtual paper trading platform.